Use of Nonsteroidal Antiinflammatory Drugs and Risk of Endometrial Cancer

被引：28

作者：

Bodelon, Clara ^{[1
]}

Doherty, Jennifer A. ^{[2
]}

Chen, Chu ^{[1
,2
]}

Rossing, Mary Anne ^{[1
,2
]}

Weiss, Noel S. ^{[1
,2
]}

机构：

[1] Univ Washington, Dept Epidemiol, Sch Publ Hlth, Seattle, WA 98195 USA

[2] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA

来源：

AMERICAN JOURNAL OF EPIDEMIOLOGY | 2009年 / 170卷 / 12期

基金：

美国国家卫生研究院;

关键词：

anti-inflammatory agents; non-steroidal; aspirin; body mass index; endometrial neoplasms;

D O I：

10.1093/aje/kwp321

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

100235 [预防医学];

摘要：

Results of 3 previous studies suggest that use of aspirin is related to a reduced risk of endometrial cancer, at least in obese women (body mass index, >= 30 kg/m(2)). Using data obtained in a population-based, case-control study in western Washington State, the authors examined this question. Between 2003 and 2005, 410 women diagnosed with invasive endometrial cancer and 356 controls were interviewed regarding the use of aspirin and other nonsteroidal antiinflammatory drugs (NSAIDs). A history of use of NSAIDs was not associated with the risk of endometrial cancer (odds ratio = 1.04, 95% confidence interval: 0.76, 1.42). The lack of association was also present specifically for use of aspirin (odds ratio = 1.06, 95% confidence interval: 0.73, 1.53). NSAID use was unrelated to risk of endometrial cancer in both obese and nonobese women. Results from this study suggest that the use of aspirin or other NSAIDs has little or no influence on the risk of endometrial cancer.

引用

页码：1512 / 1517

页数：6

共 10 条

[1]

Nonsteroidal Anti-Inflammatory Drug Use and Endometrial Cancer Risk in the NIH-AARP Diet and Health Study [J].

Danforth, Kim N. ;

Gierach, Gretchen L. ;

Brinton, Louise A. ;

Hollenbeck, Albert R. ;

Katki, Hormuzd A. ;

Leitzmann, Michael F. ;

Schatzkin, Arthur ;

Lacey, James V., Jr. .

CANCER PREVENTION RESEARCH, 2009, 2 (05) :466-472

[2]

Risk of Endometrial Cancer in Relation to Medical Conditions and Medication Use [J].

Fortuny, Joan ;

Sima, Camelia ;

Bayuga, Sharon ;

Wilcox, Homer ;

Pulick, Katherine ;

Faulkner, Shameka ;

Zauber, Ann G. ;

Olson, Sara H. .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (05) :1448-1456

[3]

Hankey BF, 1999, CANCER EPIDEM BIOMAR, V8, P1117

[4]

Kaaks R, 2002, CANCER EPIDEM BIOMAR, V11, P1531

[5]

Inflammation and endometrial cancer: A hypothesis [J].

Modugno, F ;

Ness, RB ;

Chen, C ;

Weiss, NS .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (12) :2840-2847

[6]

Regular analgesic use and risk of endometrial cancer [J].

Moysich, KB ;

Baker, JA ;

Rodabaugh, KJ ;

Villella, JA .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2005, 14 (12) :2923-2928

[7]

Menopausal hormone therapy and risk of epithelial ovarian cancer [J].

Rossing, Mary Anne ;

Cushing-Haugen, Kara L. ;

Wicklund, Kristine G. ;

Doherty, Jennifer A. ;

Weiss, Noel S. .

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2007, 16 (12) :2548-2556

[8]

Elevated C-reactive protein levels in overweight and obese adults [J].

Visser, M ;

Bouter, LM ;

McQuillan, GM ;

Wener, MH ;

Harris, TB .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (22) :2131-2135

[9]

Aspirin, NSAID, and acetaminophen use and the risk of endometrial cancer [J].

Viswanathan, Akila N. ;

Feskanich, Diane ;

Schernhammer, Eva S. ;

Hankinson, Susan E. .

CANCER RESEARCH, 2008, 68 (07) :2507-2513

[10]

Waksberg J., 2000, ENCY EPIDEMIOLOGIC M, P749

← 1 →